In vivo and in vitro effects of a new hypoglycemic agent, 2-(3-methylcinnamylhydrazono)-propionate (BM 42.304) on glucose metabolism in guinea pigsKÜHNLE, H. F; SCHMIDT, F. H; DEACIUC, I. V et al.Biochemical pharmacology. 1984, Vol 33, Num 9, pp 1437-1444, issn 0006-2952Article

Effets hypoglycémiants et antidiabétiques des fibratesBRUN, Jean-Marcel; VERGES, Bruno.MTE. Médecine thérapeutique endocrinologie. 2001, Vol 3, Num OCT, pp 49-53, issn 1295-9359, NS2Article

Synthesis and α-glucosidase-inhibiting activity of a new α-glucosidase inhibitor, 4-O-α-D-glucopyranosylmoranoline and its N-substituted derivativesYOSHIKUNI, Y; EZURE, Y; SETO, T et al.Chemical and pharmaceutical bulletin. 1989, Vol 37, Num 1, pp 106-109, issn 0009-2363, 4 p.Article

The acyl-amino-alkyl benzoic acid residue and the sulfonylurea containing residue of glibenclamide affect different aspects of β-cell functionNORLUND, L; SEHLIN, J.Acta physiologica scandinavica. 1984, Vol 120, Num 2, pp 283-286, issn 0001-6772Article

Effet hypoglycémiant des antidiabétiquesBOURAOUI, Kamel; CHAKER BEN SALEM; ELOUNI, Bouraoui et al.Concours médical (Paris). 2005, Vol 127, Num 7, pp 399-404, issn 0010-5309, 6 p.Article

Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranesDELEERS, M; BRASSEUR, R.Pharmacological research communications. 1986, Vol 18, Num 2, pp 129-136, issn 0031-6989Article

Identification of some potential antidiabetic compounds on impregnated silica gel G platea as their π-complexesRAJEEV JAIN; AGARWAL, D. D.Journal of liquid chromatography. 1983, Vol 6, Num 14, pp 2661-2664, issn 0148-3919Article

Hypoglycemics: Pharmacokinetic Considerations During PregnancyKLIEGER, Chagit; POLLEX, Erika; KAZMIN, Aleksey et al.Therapeutic drug monitoring. 2009, Vol 31, Num 5, pp 533-541, issn 0163-4356, 9 p.Article

Studies on hindered phenols and analogues. I: Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidationYOSHIOKA, T; FUJITA, T; KANAI, T et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 2, pp 421-428, issn 0022-2623, 8 p.Article

Sustained-release formulation of buformin hydrochlorideSAWAYANAGI, Y; SONOBE, T; KAWATA, H et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 3, pp 1049-1054, issn 0009-2363Article

New hypoglycaemic agentsHULIN, B.Progress in medicinal chemistry. 1994, Vol 31, pp 1-58, issn 0079-6468Article

Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM)RINAUDO, M. T; CURTO, M; RABBONE, I et al.Journal of diabetes and its complications. 1994, Vol 8, Num 4, pp 221-225, issn 1056-8727Conference Paper

Determination of metformin and phenformin in human plasma and urine by reversed-phase high-performance liquid chromatographyBENZI, L; MARCHETTI, P; CECCHETTI, P et al.Journal of chromatography. 1986, Vol 375, Num 1, pp 184-189, issn 0021-9673Article

Adsorption of sulfonylureas onto activated charcoal in vitroKANNISTO, H; NEUVONEN, P. J.Journal of pharmaceutical sciences. 1984, Vol 73, Num 2, pp 253-256, issn 0022-3549Article

Generic tolbutamide tablet dissolution: intralot and interlot variationAYRES, J. W; HUA-PIN HUANG; ALBERT, K et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 11, pp 1629-1634, issn 0022-3549Article

Interactions médicamenteuses et sulfamides hypoglycémiantsGIRARDIN, E; JADOT, G.Lyon Méditerranée médical. Médecine du sud-est. 1991, Vol 27, Num 9-10, pp 637-642, issn 0766-5466Article

Influence of extracellular pH upon the ionic and secretory response to gliclazide in pancreatic isletsBILLAUDEL, B; MATHIAS, P. C. F; LEBRUN, P et al.Research communications in chemical pathology and pharmacology. 1984, Vol 43, Num 1, pp 139-158, issn 0034-5164Article

Oral hypoglycaemic agents: An updateCADER ASMAL, A; MARBLE, A.Drugs (Basel). 1984, Vol 28, Num 1, pp 62-78, issn 0012-6667Article

LES NOUVEAUX ANTIDIABÉTIQUES: LES MÉDICATIONS « INCRÉTINES »CHARBONNE, B.Actualités néphrologiques Jean Hamburger. 2010, pp 43-51, issn 1168-1098, 9 p.Article

L'insuline détémir (Levemir®)BUYSSCHAERT, M.Louvain médical. 2005, Vol 124, Num 8, pp 340-344, issn 0024-6956, 5 p.Article

The pharma market as reflected by patents : Information market as reflected by patentsHABERNICKEL, V. J.Arzneimittel-Forschung. 1999, Vol 49, Num 10, pp 864-867, issn 0004-4172Article

Les sulfamides hypoglycemiants, 50 ans après Loubatières = Hypoglycaemic sulphonamidesSCHEEN, A. J.RMLG. Revue médicale de Liège. 1996, Vol 51, Num 1, pp 90-93, issn 0370-629XArticle

The comparative effects of tolbutamide and the non-hypoglycemic analog carboxy-tolbutamide on guanylate cyclase activityVESELY, D. L.Hormone and metabolic research. 1986, Vol 18, Num 1, pp 10-13, issn 0018-5043Article

Variations de la glycémie liées aux médicaments. Problèmes particuliers chez les malades. Conséquences sur le traitement = Drug-induced modifications of glycemia therapeutic consequencesFOUSSARD-BLANPIN, O; PICARD, H; MOUSSARD, L et al.Lyon pharmaceutique. 1985, Vol 36, Num 6, pp 293-301, issn 0024-7804Article

Effect of hypoglycemic sulfonylureas on Ca²⁺ fluxes across lipid bilayersGYLFE, E; HELLMAN, B; ARVIDSON, G et al.Biochemical medicine. 1984, Vol 31, Num 2, pp 246-253, issn 0006-2944Article